Serum Institute has produced five to six million Covovax doses: Adar Poonawalla Ruchika Sharma24 April 2023 1:30 PM ISTCovovax is the only COVID vaccine made in India which is approved in the US and Europe. Currently, the demand is very small, Poonawalla said.
SII in talks on fill finishing Oxford University R21 malaria vaccine in Ghana: Expert Ruchika Sharma21 April 2023 1:15 PM ISTBengaluru: Vaccine manufacturer Serum Institute of India is holding talks on fill-finishing Oxford University's R21 malaria vaccine in Ghana, which...
Revise Phase I/II CT protocol: CDSCO panel tells Serum Institute of India on Dengue Tetravalent Vaccine Dr. Divya Colin17 April 2023 6:00 PM ISTNew Delhi: Regarding the Phase I/II clinical trial of Dengue Tetravalent Vaccine (Live, Attenuated), the Subject Expert Committee (SEC) functional...
University of Oxford Malaria vaccine gets regulatory clearance for use in Ghana Ruchika Sharma14 April 2023 12:07 PM ISTThe vaccine has been approved for use in children aged 5 to 36 months, the age group at highest risk of death from malaria.
Rise in COVID cases: Serum Institute restarts manufacturing of Covishield Ruchika Sharma13 April 2023 2:15 PM ISTNew Delhi: Serum Institute of India (SII) CEO Adar Poonawalla on Wednesday said it has restarted manufacturing of COVID-19 vaccine Covishield amid...
SII Covovax as heterologous booster to be available on CoWIN soon; to cost Rs 225 per dose Roshni Dhar12 April 2023 11:21 AM ISTIn view of rising cases of COVID-19 in various parts of the country, Union Health Minister Mansukh Mandaviya is learnt to have approved the inclusion...
Health Bulletin 11/April/2023 Roshni Dhar11 April 2023 4:34 PM ISTHere are the top health stories for the day:Weekly cases up 79% as Covid hits more statesIndia has observed the highest weekly count of COVID...
Serum Institute Covovax likely to be available at Rs 225 per dose on CoWIN portal Ruchika Sharma10 April 2023 2:00 PM ISTCovovax was granted emergency-use listing by the World Health Organization on December 17, 2021.
COVID vaccine: SII seeks inclusion of Covovax on CoWIN as heterologous booster dose for adults Ruchika Sharma4 April 2023 11:00 AM ISTCovovax is manufactured through technology transfer from US-based vaccine maker Novavax.
Revise Phase II/III CT protocol of Yellow Fever Vaccine Live: CDSCO Panel Tells Serum Institute of India Dr. Divya Colin4 March 2023 6:00 PM ISTNew Delhi: Reviewing the proposal presented by the vaccine maker Serum Institute of India to conduct Phase II/III clinical trial of Yellow Fever...
Wockhardt plans to roll out two vaccines within year from UK facility as part of a tie-up with SII Ruchika Sharma27 Feb 2023 2:30 PM ISTNew Delhi: Drug firm Wockhardt plans to roll out two vaccines within a year from its UK-based facility as part of a tie-up with Serum Institute...
SII to establish Dr Cyrus Poonawalla Centre of Excellence in Infectious Diseases and Pandemic Preparedness at Hyderabad MD Bureau20 Feb 2023 1:30 PM ISTThe facility will serve as a hub for public health education, outreach, and response efforts during outbreaks of infectious diseases.
